Latest News

Ocrelizumab approved by Medsafe

December 22, 2017 | Advocacy, Treatments

Media Release – 22 December 2017 The Multiple Sclerosis Society of New Zealand (MSNZ) is pleased that Medsafe[1] has approved the registration of ocrelizumab (Ocrevus®) for both Relapsing (RMS) and Primary Progressive (PPMS) multiple sclerosis (MS) in New Zealand.   […]


Oceans of Hope returns to NZ shores searching for crew

December 18, 2017 | Uncategorised

  In May 2015 over 85 people with MS (PwMS) travelled to Auckland to welcome Oceans of Hope, a 67-foot sailing vessel, which left Denmark in 2014 for a 17-month long journey circumnavigating the globe and providing taster sessions for […]


Educational lectures on the future of MS available now

December 7, 2017 | Research, Treatments, Uncategorised

As part of Multiple Sclerosis NZ’s 50th Anniversary, in October we held a lecture evening on the future of MS treatments. To watch lectures from two prominent speakers in their field, click on the lecture titles below: Stem Cell Transplantation […]


MSNZs position on Stem Cell Transplantation

November 9, 2017 | Advocacy, Life with MS, Research, Treatments

Following TVNZs Sunday programme last night on people with multiple sclerosis seeking stem cell transplantation overseas for their MS, the Multiple Sclerosis Society of New Zealand (MSNZ) confirms its support for the use of this treatment within a clinical trial […]


Dorothy Newman Scholarship keeping people in employment

October 9, 2017 | Education, Grants, Life with MS, Scholarships, Support

Many people with MS experience difficulties managing work with their MS particularly at times of relapse or as their condition progresses. While for many simple changes in the work place might be all that is needed to assist someone to continue with […]